CERS develops the Intercept Blood System for platelets, plasma, and IFC. These are valuable offerings for blood transfusions. CERS Intercept provides a pathogen-reduced transfusion product suite that ...
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today the CE mark approval of its next-generation LED-based illumination device, or the INT200, for the INTERCEPT Blood ...
CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (CERS) announced today that it has entered into a group purchasing agreement with Blood Centers of America (BCA), the largest blood supply ...
Cerus (CERS) Corporation announced that it has entered into a group purchasing agreement with Blood Centers of America, the largest blood supply cooperative in the U.S. BCA member blood centers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results